Get started
Author

Xin Li

ORCID: 0000-0001-5935-0142
Observed ORCID: 0000-0001-5935-0142
OpenAlex ID: A5100353700
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli
2023 · Mei Zeng, Jun Xia, et al. · Journal of Microbiology Immunology and Infection · 153
Genetic characterization of Carbapenem-Resistant Escherichia coli from China, 2015–2017
2021 · Fengtian Li, Kun Ye, et al. · BMC Microbiology · 45
PDF
Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients
2021 · Ying Li, Yang Deng, et al. · Frontiers in Pharmacology · 45
PDF
Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
2024 · Xingchen Bian, Mengyao Li, et al. · Computational and Structural Biotechnology Journal · 10
Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model
2022 · Xingyi Qu, Xingchen Bian, et al. · Molecules · 10
PDF
Evaluation of the in vitro synergy of polymyxin B-based combinations against polymyxin B -resistant gram-negative bacilli
2022 · You Li, Siwei Guo, et al. · Microbial Pathogenesis · 8
Activity of polymyxin B combined with cefepime-avibactam against the biofilms of polymyxin B-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae in in vitro and in vivo models
2024 · Miaomei Tian, Bingqian Yan, et al. · BMC Microbiology · 5
PDF
Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects
2022 · Lihua Liu, Xin Li, et al. · Clinical Pharmacology in Drug Development · 5
Pharmacokinetics and Bioequivalence of 2 Products of Fluticasone Propionate Nasal Spray in Healthy Chinese Subjects
2025 · Pengkai Wang, Yuan Li, et al. · Clinical Pharmacology in Drug Development
Works count: 9
Citation count: 281
H-index: 6
I10-index: 5
Year
Topic
Type